Peter Park, Ph.D


Diana Mandelker, M.D., Ph.D


This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, the audience QA, and a post-test. Continuing education credit is available for the webinar. 

Description: This presentation will continue the discussion of the potential use of PARP inhibitors with an emphasis on advances in laboratory practices for identification of homologous recombination deficiency in sequencing data. This session will examine the challenges inherent to biomarker testing for PARPi response, including for patients whose tumors lack mutations in BRCA1/2.

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: October 29, 2021

CE Information:


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

CMLE Credit: The ASCP designates this activity for a maximum of 1.0 Continuing Medical Laboratory Education (CMLE) credit hour. CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

SAM Credit: This activity is approved by the American Board of Pathology for up to 1.0 SAM credit. Physicians should claim only credit commensurate with the extent of their participation in the activity. Learners must pass the post-test with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.  If you are seeking continuing education credit for an accrediting board other than the ABP, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. 

“Targeting DNA Repair Pathways: Current and Future Implications of PARP Inhibitors” is an up-to-date and useful three-part webcast series that will cover: 1. The mechanism of action of PARP inhibitors and the science of Homologous Recombination Deficiency (HRD) testing, 2. Laboratory considerations (from sample acquisition to result reporting) for HRD testing, and 3. Clinical considerations for testing and treatment and the need for genetic counseling.

This program has been supported through educational grants from AstraZeneca & Merck

You may also be interested in:

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.


Course Information
Course Date:
October 29, 2019
Course Objectives
  • Define patterns of genomic alterations in tumors with homologous recombination deficiency.
  • Employ techniques for detection of homologous recombination deficiency in sequencing data.
  • Describe the clinical correlations of homologous recombination deficiency including PARPi outcomes.
Identifying Mutational Signatures of Homologous Recombination Deficiency to Predict PARPi Response
Q&A Session
Followup and Claiming CE Credit
Individual topic purchase: Selected
American Board of Pathology
Self-Assessment Module: 1.00
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Park Presentation
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00